Loading...
•
Sep 30, 2021
Akoya Q3 2021 Earnings Report
Akoya reported the highest quarterly revenue in history and a significant increase compared to the prior year.
Key Takeaways
Akoya Biosciences reported a strong third quarter with total revenue of $13.5 million, a 35% increase year-over-year. The company saw growth in both product and service revenue, and made key additions to its management team and Board of Directors.
Total revenue reached $13.5 million, a 35% increase compared to the prior year period.
Product revenue increased by 38% to $10.9 million.
Services and other revenue totaled $2.6 million, compared to $2.1 million in the prior year period.
Gross profit increased by 42% to $8.5 million with a gross profit margin of 62.7%.
Revenue by Segment
Forward Guidance
Akoya expects fourth quarter revenue of at least $15 million, and full year revenue of at least $53.8 million. Full year guidance has been increased from the prior guidance which had a range of $52.5 million to $53.0 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...